Skip to main content
Top

Current Obesity Reports

Issue 4/2023

Content (12 Articles)

Obesity REVIEW

Upstream Determinants of Overweight and Obesity in Europe

Stefanie Vandevijvere, Robby De Pauw, Sanne Djojosoeparto, Vanessa Gorasso, Leonor Guariguata, Anne Lene Løvhaug, Melissa Mialon, Iris Van Dam, Peter von Philipsborn

Open Access Obesity REVIEW

Incomplete Data and Potential Risks of Drugs in People with Obesity

Caroline M. Apovian, Christopher D. Bruno, Theodore K. Kyle, Christina R. Chow, David J. Greenblatt

Open Access Semaglutide REVIEW

The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities

Thomas A. Wadden, Ariana M. Chao, Molly Moore, Jena S. Tronieri, Adam Gilden, Anastassia Amaro, Sharon Leonard, John M. Jakicic

Open Access Obesity REVIEW

Genetics and Epigenetics in Obesity: What Do We Know so Far?

Maria Keller, Stina Ingrid Alice Svensson, Kerstin Rohde-Zimmermann, Peter Kovacs, Yvonne Böttcher

Obesity REVIEW

Revisiting Resting Metabolic Rate: What is the Relation to Weight Fluctuations?

Georgia Argyrakopoulou, Nefeli Fountouli, Maria Dalamaga, Alexander Kokkinos

Open Access Lipedema REVIEW

Ketogenic Diet: A Nutritional Therapeutic Tool for Lipedema?

Ludovica Verde, Elisabetta Camajani, Giuseppe Annunziata, Antoanstefan Sojat, Ljiljana V. Marina, Annamaria Colao, Massimiliano Caprio, Giovanna Muscogiuri, Luigi Barrea

Pediatric Obesity Care via Telemedicine: Expanding the Path Forward—A Review

Valerie M. O’Hara, Danielle Louder, Starr V. Johnston, Kathrin Hastey, Nancy T. Browne

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.